|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.92 SEK | -32.03% |
|
+17,400.00% | +13,658.62% |
| 06-15 | Immunovia Unveils New Data Ahead of Medicare Reimbursement Application | FW |
| 06-15 | Immunovia Announces New Performance Data for PancreaSure Ahead of Upcoming Application for Medicare Coverage | CI |
Company Valuation: Immunovia AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,697 | 595.2 | 92.66 | 152.7 | 134.5 | - | - |
| Change | - | -64.93% | - | 64.79% | -11.89% | - | - |
| Enterprise Value (EV) 1 | 1,443 | 526.7 | 92.66 | 76.09 | 67.53 | 60.53 | 116.5 |
| Change | - | -63.5% | - | -17.88% | -11.25% | -10.37% | 92.51% |
| P/E | -0.11x | -0.04x | -0.01x | -0.54x | -2x | -5x | -10x |
| PBR | 0.04x | 0.02x | - | - | - | - | - |
| PEG | - | -0.01x | - | 0x | 0x | 0.1x | 0.2x |
| Capitalization / Revenue | 1,775x | 494x | - | 203x | 42x | 7.78x | 2.45x |
| EV / Revenue | 1,510x | 437x | - | 101x | 21.1x | 3.5x | 2.12x |
| EV / EBITDA | -9.78x | -3.17x | - | -0.97x | -0.76x | -0.76x | -2.48x |
| EV / EBIT | -8.66x | -2.76x | - | -0.95x | -0.74x | -0.74x | -2.33x |
| EV / FCF | -9.27x | -2.97x | - | -0.91x | -0.72x | -0.7x | -2.08x |
| FCF Yield | -10.8% | -33.6% | - | -110% | -139% | -144% | -48.1% |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | -689 | -743 | -93 | -0.42 | -0.1 | -0.04 | -0.02 |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | 0.956 | 1.204 | - | 0.752 | 3.2 | 17.3 | 55 |
| EBITDA 1 | -147.6 | -166.2 | - | -78.06 | -89 | -80 | -47 |
| EBIT 1 | -166.6 | -191.2 | - | -80.38 | -91 | -82 | -50 |
| Net income 1 | -156 | -168.1 | -76.54 | -145.9 | -91 | -82 | -50 |
| Net Debt 1 | -254.1 | -68.47 | - | -76.6 | -67 | -74 | -18 |
| Reference price 2 | 75.0000 | 26.3000 | 0.5460 | 0.2270 | 0.2000 | 0.2000 | 0.2000 |
| Nbr of stocks (in thousands) | 22,632 | 22,632 | 169,711 | 672,667 | 672,667 | - | - |
| Announcement Date | 17/02/22 | 23/02/23 | 25/02/25 | 24/02/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 55.92x | 4.59x | 15.32x | 0.39% | 15.63B | ||
| 36.59x | - | - | 2.21% | 1.57B | ||
| 18.56x | 2.67x | 8.97x | 2.12% | 1.12B | ||
| -8.54x | 1.19x | 5.22x | -.--% | 932M | ||
| 54.21x | - | - | 0.83% | 554M | ||
| 45.29x | - | - | - | 444M | ||
| 18.55x | 2.61x | 11.17x | 1.84% | 382M | ||
| 22.49x | 3.95x | 13.3x | 2.01% | 341M | ||
| Average | 30.38x | 3.00x | 10.80x | 1.34% | 2.62B | |
| Weighted average by Cap. | 48.12x | 4.25x | 14.30x | 0.67% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- IMMNOV Stock
- 0G8X Stock
- Valuation Immunovia AB
Select your edition
All financial news and data tailored to specific country editions
















